Teneurin-4 knockdown disrupts dopamine dynamics and attenuates methamphetamine-induced behaviors.
Saved in:
| Title: | Teneurin-4 knockdown disrupts dopamine dynamics and attenuates methamphetamine-induced behaviors. |
|---|---|
| Authors: | Chen W; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan., Yokose J; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan., Izuo N; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan; Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan., Yano Y; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan., Kaigawa T; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan., Kai N; Division for Memory and Cognitive Function, Research Center for Advanced Medical Science, Comprehensive Research Facilities for Advanced Medical Science, Dokkyo Medical University, Tochigi, Japan., Kamiyoshihara C; Division for Memory and Cognitive Function, Research Center for Advanced Medical Science, Comprehensive Research Facilities for Advanced Medical Science, Dokkyo Medical University, Tochigi, Japan., Ohkawa N; Division for Memory and Cognitive Function, Research Center for Advanced Medical Science, Comprehensive Research Facilities for Advanced Medical Science, Dokkyo Medical University, Tochigi, Japan., Shigetsura Y; Department of Clinical Pharmacology and Therapeutics, Kyoto University, Japan., Muramatsu SI; Division of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, Shimotsuke, Japan; Center for Gene and Cell Therapy, The Institute of Medical Sciences, The University of Tokyo, Tokyo, Japan., Nitta A; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan. Electronic address: nitta@pha.u-toyama.ac.jp. |
| Source: | Neuropharmacology [Neuropharmacology] 2026 Mar 15; Vol. 286, pp. 110817. Date of Electronic Publication: 2025 Dec 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41448359 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Teneurin-4 knockdown disrupts dopamine dynamics and attenuates methamphetamine-induced behaviors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chen+W%22">Chen W</searchLink>; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Yokose+J%22">Yokose J</searchLink>; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Izuo+N%22">Izuo N</searchLink>; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan; Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yano+Y%22">Yano Y</searchLink>; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Kaigawa+T%22">Kaigawa T</searchLink>; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Kai+N%22">Kai N</searchLink>; Division for Memory and Cognitive Function, Research Center for Advanced Medical Science, Comprehensive Research Facilities for Advanced Medical Science, Dokkyo Medical University, Tochigi, Japan.<br /><searchLink fieldCode="AU" term="%22Kamiyoshihara+C%22">Kamiyoshihara C</searchLink>; Division for Memory and Cognitive Function, Research Center for Advanced Medical Science, Comprehensive Research Facilities for Advanced Medical Science, Dokkyo Medical University, Tochigi, Japan.<br /><searchLink fieldCode="AU" term="%22Ohkawa+N%22">Ohkawa N</searchLink>; Division for Memory and Cognitive Function, Research Center for Advanced Medical Science, Comprehensive Research Facilities for Advanced Medical Science, Dokkyo Medical University, Tochigi, Japan.<br /><searchLink fieldCode="AU" term="%22Shigetsura+Y%22">Shigetsura Y</searchLink>; Department of Clinical Pharmacology and Therapeutics, Kyoto University, Japan.<br /><searchLink fieldCode="AU" term="%22Muramatsu+SI%22">Muramatsu SI</searchLink>; Division of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, Shimotsuke, Japan; Center for Gene and Cell Therapy, The Institute of Medical Sciences, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nitta+A%22">Nitta A</searchLink>; Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan. Electronic address: nitta@pha.u-toyama.ac.jp. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220236217%22">Neuropharmacology</searchLink> [Neuropharmacology] 2026 Mar 15; Vol. 286, pp. 110817. <i>Date of Electronic Publication: </i>2025 Dec 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pergamon+Press%22">Pergamon Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0236217 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-7064 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200283908%22">00283908 </searchLink><i>NLM ISO Abbreviation: </i>Neuropharmacology <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41448359 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.neuropharm.2025.110817 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 110817 Titles: – TitleFull: Teneurin-4 knockdown disrupts dopamine dynamics and attenuates methamphetamine-induced behaviors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chen W – PersonEntity: Name: NameFull: Yokose J – PersonEntity: Name: NameFull: Izuo N – PersonEntity: Name: NameFull: Yano Y – PersonEntity: Name: NameFull: Kaigawa T – PersonEntity: Name: NameFull: Kai N – PersonEntity: Name: NameFull: Kamiyoshihara C – PersonEntity: Name: NameFull: Ohkawa N – PersonEntity: Name: NameFull: Shigetsura Y – PersonEntity: Name: NameFull: Muramatsu SI – PersonEntity: Name: NameFull: Nitta A IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 03 Text: 2026 Mar 15 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-7064 Numbering: – Type: volume Value: 286 Titles: – TitleFull: Neuropharmacology Type: main |
| ResultId | 1 |